Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Years of life lost associated with leading causes of US death during the first 20 months of the COVID-19 pandemic

Years of life lost associated with leading causes of US death during the first 20 months of the COVID-19 pandemic

Genetic information from bats may help prevent and manage future pandemics, suggests study

Genetic information from bats may help prevent and manage future pandemics, suggests study

Study finds molnupiravir well-tolerated, and effective in vaccinated and unvaccinated

Study finds molnupiravir well-tolerated, and effective in vaccinated and unvaccinated

Icelandic study reveals how many children experience severe COVID symptoms

Icelandic study reveals how many children experience severe COVID symptoms

Efficacy of COVID mRNA vaccines among patients on CAR‐T‐lymphocyte therapy

Efficacy of COVID mRNA vaccines among patients on CAR‐T‐lymphocyte therapy

Efficacy of monoclonal antibodies against Omicron BA.1, BA.2, and BA.5

Efficacy of monoclonal antibodies against Omicron BA.1, BA.2, and BA.5

Incorporating a coronavirus antigen into MMR vaccine to produce COVID-19 immunity in kids

Incorporating a coronavirus antigen into MMR vaccine to produce COVID-19 immunity in kids

A comparison of SARS-CoV-2 antibody profiles in elderly and younger individuals

A comparison of SARS-CoV-2 antibody profiles in elderly and younger individuals

Highly specialized T cells remain in blood 20 months after COVID-19

Highly specialized T cells remain in blood 20 months after COVID-19

The nose key to winning the war against COVID-19

The nose key to winning the war against COVID-19

Specific area of SARS-CoV-2 spike protein found to be a promising target for pan-coronavirus vaccine

Specific area of SARS-CoV-2 spike protein found to be a promising target for pan-coronavirus vaccine

India, Pakistan tackle backslide in child immunizations

India, Pakistan tackle backslide in child immunizations

Investigating an effective linear deoxyribonucleic acid COVID-19 vaccine option for domestic cats

Investigating an effective linear deoxyribonucleic acid COVID-19 vaccine option for domestic cats

Increased resistance to human interferons could be a potential driver of SARS-CoV-2 evolution

Increased resistance to human interferons could be a potential driver of SARS-CoV-2 evolution

Study shows SARS-CoV-2 impairs interferon production through NSP2-induced repression of mRNA translation

Study shows SARS-CoV-2 impairs interferon production through NSP2-induced repression of mRNA translation

Study shows the emerging Omicron sublineage BA.2.75 does not show greater immune evasion than BA.5

Study shows the emerging Omicron sublineage BA.2.75 does not show greater immune evasion than BA.5

UK study finds over 100 symptoms of long COVID in non-hospitalized adults

UK study finds over 100 symptoms of long COVID in non-hospitalized adults

Novel compound inhibits SARS-CoV-2 replication by binding a genome target

Novel compound inhibits SARS-CoV-2 replication by binding a genome target

Scientists explore post-COVID-19 conditions among children

Scientists explore post-COVID-19 conditions among children

Scientists explore associations between SARS-CoV-2 neutralizing antibodies and receptor-binding domain-selective proliferative memory CD4 T cells

Scientists explore associations between SARS-CoV-2 neutralizing antibodies and receptor-binding domain-selective proliferative memory CD4 T cells

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.